The continuous increase in PD-L1 expression in both tumor cells and tumor-associated inflammatory cells with increasing levels of STING expression in tumor cells represents a strong confirmation of studies showing a functional relationship between STING activation and PD-L1 upregulation in cancer cells. The gene discussed is STING1; the disease is neoplasm.